NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/05/2025
Back to search
Official data from USPTO
MAC CLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
MAC CLINICAL RESEARCH
ST13
US500000079343442Class
42
Filing
79343442
Registration
7369379
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
12/06/2025
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
05/12/2022
Registration date
04/30/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/30/2024
Last transaction
12/06/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
01
Owner location
GB
Examiner
GAINES,LEAH R
Law office
L60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
M. D. (pessoa física)
Representatives
Janet F. Satterthwaite Potomac Law Group, PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Advisory services relating to scientific researchcontract research services in the field of pharmaceuticals and the clinical sector; research and development of new products; laboratory research services relating to pharmaceuticals; management of scientific research projectsconsulting services for others in the field of designplanning and implementationproject management of scientific researchpharmaceutical research and clinical trials; medical research; pharmaceutical research services; preparation of reports relating to scientific research; provision of information relating to scientific research; provision of research services in the field of pharmaceuticals and the clinical sector; scientific research; research and development for others in the field of pharmaceuticals and the clinical sector; research into new products; research relating to biotechnology; research relating to medicine; research relating to medicines; research relating to pharmaceuticals; scientific research into the development of new products
Publications
History of USPTO decisions and trademark events.
34 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/17/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/25/2024
FIMP
FINAL DISPOSITION PROCESSED
10/25/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/30/2024
GPNX
NOTIFICATION PROCESSED BY IB
07/01/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/13/2024
PUBO
PUBLISHED FOR OPPOSITION
02/13/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/24/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/24/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/10/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/18/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/29/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/29/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/07/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/02/2023
RFNT
REFUSAL PROCESSED BY IB
06/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/08/2023
RFRR
REFUSAL PROCESSED BY MPU
05/08/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/18/2023
CNRT
NON-FINAL ACTION WRITTEN
03/17/2023
DOCK
ASSIGNED TO EXAMINER
03/02/2023
MAFR
APPLICATION FILING RECEIPT MAILED
06/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/24/2022
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
06/23/2022
Continuous trademark protection
Get notified about every new filing that threatens MAC CLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.